Stay updated with breaking news from Global Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exonate Ltd., a biotechnology company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases, today announced the expansion of its Board with the appointment of Dr Rafiq Hasan as Non-Executive Director. Rafiq brings extensive expertise in ophthalmology, specifically within the diabetic eye disease sector, from his years in global pharmaceutical businesses.
EXONATE APPOINTS DR RAFIQ HASAN AS NON-EXECUTIVE DIRECTOR Appointment brings extensive experience in global pharma leadership and progressing ophthalmology drugs to market and further strengthens
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / The Consumer Goods ForumThis series by the Consumer Goods Forum aims to mobilise member action around five 'Acceleration Areas'On Wednesday 15 May 2024, the
US consumer confidence data from The Conference Board for May 2024
The limited-time release is the latest in a long-standing partnership between retailer and brand